Step 5 Ongoing Care Through the Patient Portal Once enrolled, all ongoing account activity refills, dose adjustments, messaging with the care team, billing, and tracking is managed through the Direct Meds patient portal
What the research shows Large clinical trials established that GLP-1 receptor agonists lower A1c and support meaningful weight reduction in studied populations, and cardiovascular outcome trials have examined their effects on heart-related endpoints
They are not licensed under the Human Medicines Regulations 2012
Ignoring Individual Response Signals The Problem: Rigidly adhering to a protocol despite clear signs it's not optimal for your body
Patients interested in learning more about treatment expectations, side effects, and weight loss results may also review the Semaglutide Weight Loss Guide, Semaglutide Side Effects Guide, and Semaglutide vs Tirzepatide comparison
Consult with our healthcare professional to develop a schedule thats right for you